On June 16, 2015, LifeVac Europe received confirmation from the UK Ministry of Health that LifeVac is now registered in the Medicines and Healthcare products Regulatory Agency public access data base. This is the final step towards acquiring the CE mark and making LifeVac available to the entire European market.
“We are very excited to expand LifeVac’s reach outside the United States,” said Arthur Lih, president and founder of LifeVac. “It has always been our goal to reduce the number of choking deaths worldwide and this is an important step in achieving this. We will continue to work to ensure LifeVac is available to every person anywhere in the world.”